{"disease":{"id":"hyperkalemia","name":"Hyperkalemia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":7,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"calcium-glycerylphosphate","indication_name":"Hyperkalemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcium Glycerophosphate","generic_name":"calcium glycerylphosphate","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"calcium glycerylphosphate","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"calcium-lactate","indication_name":"Hyperkalemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CALCIUM LACTATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"calcium lactate","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"calcium-glucoheptonate","indication_name":"Hyperkalemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcium Gluceptate","generic_name":"calcium glucoheptonate","company_name":"Abbott","drug_phase":"marketed","molecular_target":"","drug_class":"calcium glucoheptonate","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"calcium-polystyrene-sulfonate","indication_name":"Hyperkalemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kalimate","generic_name":"calcium polystyrene sulfonate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Kalimate works by exchanging potassium ions in the blood for calcium ions."},{"drug_id":"calcium-chloride","indication_name":"Hyperkalemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Plegisol In Plastic Container","generic_name":"CALCIUM CHLORIDE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"calcium chloride","quality_score":50,"revenue":null,"mechanism":"Calcium chloride works by replenishing calcium levels in the body, which is essential for maintaining proper muscle and nerve function."},{"drug_id":"sodium-polystyrene-sulfonate","indication_name":"Hyperkalemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sps","generic_name":"SODIUM POLYSTYRENE SULFONATE","company_name":"Concordia","drug_phase":"marketed","molecular_target":"","drug_class":"Potassium Binder [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"calcium-acetate","indication_name":"Hyperkalemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phoslo","generic_name":"CALCIUM ACETATE","company_name":"Fresenius Medcl Care","drug_phase":"marketed","molecular_target":"","drug_class":"calcium acetate","quality_score":75,"revenue":null,"mechanism":"Phoslo works by increasing calcium levels in the blood to treat conditions related to low calcium."}],"pipeline":[],"offLabel":[],"totalMarketed":7,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03657875","title":"Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)","phase":"","overall_status":"COMPLETED","enrollment_count":53940,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06763549","title":"COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15000,"lead_sponsor_name":"Peerbridge Health, Inc","has_results":false},{"nct_id":"NCT05118022","title":"Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)","phase":"NA","overall_status":"COMPLETED","enrollment_count":14989,"lead_sponsor_name":"National Defense Medical Center, Taiwan","has_results":false},{"nct_id":"NCT05184998","title":"Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels","phase":"","overall_status":"COMPLETED","enrollment_count":6950,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07370194","title":"Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6215,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04847232","title":"Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":2690,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04864795","title":"Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia","phase":"","overall_status":"COMPLETED","enrollment_count":2636,"lead_sponsor_name":"Vifor (International) Inc.","has_results":false},{"nct_id":"NCT06940414","title":"Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community","phase":"","overall_status":"RECRUITING","enrollment_count":1890,"lead_sponsor_name":"Xiujuan Zang","has_results":false},{"nct_id":"NCT05408039","title":"Tracking Treatment Pathways in Adult Patients With Hyperkalemia.","phase":"","overall_status":"COMPLETED","enrollment_count":1331,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03833089","title":"Targeted Potassium Levels for Prevention of ICD Therapy","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03888066","title":"Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1195,"lead_sponsor_name":"Vifor Pharma, Inc.","has_results":true},{"nct_id":"NCT05441852","title":"A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG)","phase":"","overall_status":"COMPLETED","enrollment_count":1151,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05056727","title":"A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1112,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT06884267","title":"Hyperkalemia Quality Improvement Program (HK-QIP) Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT01737697","title":"Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":754,"lead_sponsor_name":"ZS Pharma, Inc.","has_results":true},{"nct_id":"NCT02163499","title":"Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":751,"lead_sponsor_name":"ZS Pharma, Inc.","has_results":true},{"nct_id":"NCT04799067","title":"Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04141800","title":"Spanish Study of Hyperkalaemia Incidence and Prognosis in Patients With Heart Failure and Reduced Ejection Fraction","phase":"","overall_status":"COMPLETED","enrollment_count":565,"lead_sponsor_name":"Spanish Society of Cardiology","has_results":false},{"nct_id":"NCT03253172","title":"Potassium Supplementation in CKD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":532,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04012138","title":"Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":525,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT06036823","title":"5 Versus 10 Units of Insulin in Hyperkalemia Management","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"Oman Medical Speciality Board","has_results":false},{"nct_id":"NCT05297409","title":"An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure","phase":"","overall_status":"COMPLETED","enrollment_count":352,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03071263","title":"Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":295,"lead_sponsor_name":"Relypsa, Inc.","has_results":true},{"nct_id":"NCT03528681","title":"A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT02875834","title":"A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":267,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05136664","title":"Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":262,"lead_sponsor_name":"Vifor Fresenius Medical Care Renal Pharma","has_results":false},{"nct_id":"NCT02088073","title":"Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":258,"lead_sponsor_name":"ZS Pharma, Inc.","has_results":true},{"nct_id":"NCT02609841","title":"POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"ZS Pharma, Inc.","has_results":true},{"nct_id":"NCT02607085","title":"REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"ZS Pharma, Inc.","has_results":false},{"nct_id":"NCT03303521","title":"A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03799926","title":"Exploratory Study of ZG-801 for the Treatment of Hyperkalemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"Zeria Pharmaceutical","has_results":false},{"nct_id":"NCT03172702","title":"Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04466969","title":"Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study","phase":"","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06277128","title":"A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Waterstone Pharmaceutical (Wuhan) Co., LTD.","has_results":false},{"nct_id":"NCT04217590","title":"Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05004363","title":"Lokelma for RAAS Maximisation in CKD & Heart Failure.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"St George's, University of London","has_results":false},{"nct_id":"NCT02107092","title":"Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"ZS Pharma, Inc.","has_results":true},{"nct_id":"NCT06029179","title":"SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT04443608","title":"Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":115,"lead_sponsor_name":"Comprehensive Research Associates","has_results":false},{"nct_id":"NCT04789239","title":"OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Michael Fu","has_results":false},{"nct_id":"NCT04780841","title":"A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Ardelyx","has_results":false},{"nct_id":"NCT03127644","title":"ZS Ph2/3 Dose-response Study in Japan","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05860491","title":"Dietary Fiber and Hyperkalemia in Dialysis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT06736184","title":"the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT01493024","title":"Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"ZS Pharma, Inc.","has_results":true},{"nct_id":"NCT05535920","title":"A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"NephroNet, Inc.","has_results":false},{"nct_id":"NCT04955678","title":"A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Zeria Pharmaceutical","has_results":false},{"nct_id":"NCT06428942","title":"Low-potassium Content Vegetables in Chronic Kidney Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","has_results":false},{"nct_id":"NCT04256369","title":"Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes","phase":"","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"King Faisal Specialist Hospital & Research Center","has_results":false},{"nct_id":"NCT03337477","title":"A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"AstraZeneca","has_results":true}],"total":50},"guidelines":[{"drug_id":"tpn-electrolytes-in-plastic-container","guideline_body":"FDA label","recommendation":"Calcium Chloride (Plegisol) may be used to treat hyperkalemia.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"tpn-electrolytes-in-plastic-container","guideline_body":"FDA label","recommendation":"Calcium Chloride (Plegisol) may be used to treat hypermagnesemia.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"tpn-electrolytes-in-plastic-container","guideline_body":"FDA label","recommendation":"Calcium Chloride (Plegisol) may be used to treat hypocalcemia.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"tpn-electrolytes-in-plastic-container","guideline_body":"FDA label","recommendation":"Calcium Chloride (Plegisol) may be used to treat hypocalcemic tetany.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"tpn-electrolytes-in-plastic-container","guideline_body":"FDA label","recommendation":"Calcium Chloride (Plegisol) may be used to treat hypokalemia.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}